Nanoimaging for prion related diseases

Prion

Volumn 4, Issue 4, 2010, Pages 265-274

  Krasnoslobodtsev, Alexey V ^a   Portillo, Alexander M ^a   Deckert Gaudig, Tanja ^b   Deckert, Volker ^b   Lyubchenko, Yuri L ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Atomic force microscopy; Force spectroscopy; Nanomedicine; Prion; Protein misfolding

Indexed keywords

PRION PROTEIN;

BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; FATAL FAMILIAL INSOMNIA; FIBER; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; HUMAN; KURU; NANOIMAGING; NERVE DEGENERATION; NONHUMAN; PRION DISEASE; PROTEIN AGGREGATION; PROTEIN FOLDING; PROTEIN POLYMORPHISM; PROTEIN STRUCTURE; REVIEW;

AMYLOID; ANIMALS; DIAGNOSTIC IMAGING; HUMANS; NANOTECHNOLOGY; PRION DISEASES; PRIONS; SPECIES SPECIFICITY;

BOS; BOVINAE; FUNGI; MAMMALIA; MAMMALIAN PRION;

EID: 78650206856     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: 10.4161/pri.4.4.13125     Document Type: Review

References (101)

1. Collinge J, Clarke AR. A general model of prion strains and their pathogenicity. Science 2007; 318:930-6. (Pubitemid 350098981)
2. Baxa U, Wickner RB, Steven AC, Anderson DE, Marekov LN, Yau WM, et al. Characterization of beta-sheet structure in Ure2p1-89 yeast prion fibrils by solid-state nuclear magnetic resonance. Biochemistry 2007; 46:13149-62.
3. Chan JC, Oyler NA, Yau WM, Tycko R. Parallel beta-sheets and polar zippers in amyloid fibrils formed by residues 10-39 of the yeast prion protein Ure2p. Biochemistry 2005; 44:10669-80.
4. Shewmaker F, Wickner RB, Tycko R. Amyloid of the prion domain of Sup35p has an in-register parallel beta-sheet structure. Proc Natl Acad Sci USA 2006; 103:19754-9.
5. Wickner RB, Dyda F, Tycko R. Amyloid of Rnq1p, the basis of the [PIN+] prion, has a parallel in-register beta-sheet structure. Proc Natl Acad Sci USA 2008; 105:2403.
6. Diaz-Avalos R, King CY, Wall J, Simon M, Caspar DL. Strain-specific morphologies of yeast prion amyloid fibrils. Proc Natl Acad Sci USA 2005; 102:10165-70.
7. Balbach JJ, Petkova AT, Oyler NA, Antzutkin ON, Gordon DJ, Meredith SC, et al. Supramolecular structure in full-length Alzheimer's beta-amyloid fibrils: evidence for a parallel beta-sheet organization from solid-state nuclear magnetic resonance. Biophys J 2002; 83:1205-16.
8. Petkova AT, Buntkowsky G, Dyda F, Leapman RD, Yau WM, Tycko R. Solid state NMR reveals a pH-dependent antiparallel beta-sheet registry in fibrils formed by a beta-amyloid peptide. J Mol Biol 2004; 335:247-60.
9. Sawaya MR, Sambashivan S, Nelson R, Ivanova MI, Sievers SA, Apostol MI, et al. Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature 2007; 447:453-7.
10. Madine J, Doig AJ, Kitmitto A, Middleton DA. Studies of the aggregation of an amyloidogenic alpha-synuclein peptide fragment. Biochem Soc Trans 2005; 33:1113-5.
11. Tenidis K, Waldner M, Bernhagen J, Fischle W, Bergmann M, Weber M, et al. Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties. J Mol Biol 2000; 295:1055-71.
12. Krebs MR, Wilkins DK, Chung EW, Pitkeathly MC, Chamberlain AK, Zurdo J, et al. Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the beta-domain. J Mol Biol 2000; 300:541-9.
13. Ivanova MI, Sawaya MR, Gingery M, Attinger A, Eisenberg D. An amyloid-forming segment of beta2-microglobulin suggests a molecular model for the fibril. Proc Natl Acad Sci USA 2004; 101:10584-9. (Pubitemid 38955785)
14. Lopez de la Paz M, Serrano L. Sequence determinants of amyloid fibril formation. Proc Natl Acad Sci USA 2004; 101:87-92.
15. Esteras-Chopo A, Serrano L, Lopez de la Paz M. The amyloid stretch hypothesis: recruiting proteins toward the dark side. Proc Natl Acad Sci USA 2005; 102:16672-7.
16. Keskin O, Ma B, Nussinov R. Hot regions in protein - protein interactions: the organization and contribution of structurally conserved hot spot residues. J Mol Biol 2005; 345:1281-94.
17. Sanchez de Groot N, Pallares I, Aviles FX, Vendrell J, Ventura S. Prediction of "hot spots" of aggregation in disease-linked polypeptides. BMC Struct Biol 2005; 5:18.
18. Tessier PM, Lindquist S. Prion recognition elements govern nucleation, strain specificity and species barriers. Nature 2007; 447:556-61.
19. Nelson R, Sawaya MR, Balbirnie M, Madsen AO, Riekel C, Grothe R, et al. Structure of the cross-beta spine of amyloid-like fibrils. Nature 2005; 435:773-8.
20. Kadnar ML, Articov G, Derkatch IL. Distinct type of transmission barrier revealed by study of multiple prion determinants of Rnq1. PLoS Genet 2010; 6:1000824.
21. Ohhashi Y, Ito K, Toyama BH, Weissman JS, Tanaka M. Differences in prion strain conformations result from non-native interactions in a nucleus. Nat Chem Biol 2010; 6:225-30.
22. Collins SR, Douglass A, Vale RD, Weissman JS. Mechanism of prion propagation: amyloid growth occurs by monomer addition. PLoS Biol 2004; 2:321.
23. Ban T, Hamada D, Hasegawa K, Naiki H, Goto Y. Direct observation of amyloid fibril growth monitored by thioflavin T fluorescence. J Biol Chem 2003; 278:16462-5.
24. Ban T, Goto Y. Direct observation of amyloid growth monitored by total internal reflection fluorescence microscopy. Methods Enzymol 2006; 413:91-102. (Pubitemid 44528686)
25. Ban T, Hoshino M, Takahashi S, Hamada D, Hasegawa K, Naiki H, et al. Direct observation of Abeta amyloid fibril growth and inhibition. J Mol Biol 2004; 344:757-67.
26. Hoyer W, Cherny D, Subramaniam V, Jovin TM. Rapid self-assembly of alpha-synuclein observed by in situ atomic force microscopy. J Mol Biol 2004; 340:127-39.
27. Kowalewski T, Holtzman DM. In situ atomic force microscopy study of Alzheimer's beta-amyloid peptide on different substrates: new insights into mechanism of beta-sheet formation. Proc Natl Acad Sci USA 1999; 96:3688-93.
28. Goldsbury C, Kistler J, Aebi U, Arvinte T, Cooper GJ. Watching amyloid fibrils grow by time-lapse atomic force microscopy. J Mol Biol 1999; 285:33-9.
29. Goldsbury C, Green J. Time-lapse atomic force microscopy in the characterization of amyloid-like fibril assembly and oligomeric intermediates. Methods Mol Biol 2005; 299:103-28.
30. Kellermayer MS, Karsai A, Benke M, Soos K, Penke B. Stepwise dynamics of epitaxially growing single amyloid fibrils. Proc Natl Acad Sci USA 2008; 105:141-4.
31. DePace AH, Weissman JS. Origins and kinetic consequences of diversity in Sup35 yeast prion fibers. Nat Struct Biol 2002; 9:389-96.
32. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95:13363-83.
33. Morales R, Abid K, Soto C. The prion strain phenomenon: molecular basis and unprecedented features. Biochim Biophys Acta 2007; 1772:681-91.
34. Petkova AT, Leapman RD, Guo Z, Yau WM, Mattson MP, Tycko R. Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils. Science 2005; 307:262-5.
35. Tanaka M, Chien P, Yonekura K, Weissman JS. Mechanism of cross-species prion transmission: an infectious conformation compatible with two highly divergent yeast prion proteins. Cell 2005; 121:49-62.
36. Jones EM, Surewicz WK. Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids. Cell 2005; 121:63-72. (Pubitemid 40501168)
37. Makarava N, Ostapchenko VG, Savtchenko R, Baskakov IV. Conformational switching within individual amyloid fibrils. J Biol Chem 2009; 284:14386-95.
38. van der Wel PC, Lewandowski JR, Griffin RG. Solid-state NMR study of amyloid nanocrystals and fibrils formed by the peptide GNNQQNY from yeast prion protein Sup35p. J Am Chem Soc 2007; 129:5117-30.
39. Novitskaya V, Makarava N, Bellon A, Bocharova OV, Bronstein IB, Williamson RA, et al. Probing the conformation of the prion protein within a single amyloid fibril using a novel immunoconformational assay. J Biol Chem 2006; 281:15536-45.
40. Petty SA, Decatur SM. Intersheet rearrangement of polypeptides during nucleation of {beta}-sheet aggregates. Proc Natl Acad Sci USA 2005; 102:14272-7.
41. Shim SH, Gupta R, Ling YL, Strasfeld DB, Raleigh DP, Zanni MT. Two-dimensional IR spectroscopy and isotope labeling defines the pathway of amyloid formation with residue-specific resolution. P Natl Acad Sci USA 2009; 106:6614-9.
42. Shashilov V, Xu M, Ermolenkov VV, Fredriksen L, Lednev IK. Probing a fibrillation nucleus directly by deep ultraviolet Raman spectroscopy. J Am Chem Soc 2007; 129:6972-3.
43. Shashilov VA, Lednev IK. 2D correlation deep UV resonance raman spectroscopy of early events of lysozyme fibrillation: kinetic mechanism and potential interpretation pitfalls. J Am Chem Soc 2008; 130:309-17.
44. Paulite M, Fakhraai Z, Gunari N, Tanur A, GW. Different Individual Amyloid Fibrils Exhibit Different Beta Sheet Secondary Structures via Near-field Infrared Spectroscopy. Biophys J 2009; 96:87.
45. Paulite M, Fakhraai Z, Akhremitchev BB, Mueller K, Walker GC. Assembly, tuning and use of an apertureless near field infrared microscope for protein imaging. J Vis Exp 2009.
46. Stockle RM, Suh YD, Deckert V, Zenobi R. Nanoscale chemical analysis by tip-enhanced Raman spectroscopy. Chem Phys Lett 2000; 318:131-6.
47. Hayazawa N, Inouye Y, Sekkat Z, Kawata S. Metallized tip amplification of near-field Raman scattering. Optics Communications 2000; 183:333-6.
48. Pettinger B, Picardi G, Schuster G, Ertl G. Surface enhanced Raman spectroscopy: towards single molecule spectroscopy. Electrochem 2000; 68:942-9.
49. Bailo E, Deckert V. Tip-enhanced Raman scattering. Chem Soc Rev 2008; 37:921-30.
50. Neacsu CC, Dreyer J, Behr N, Raschke MB. Reply to Comment on "Scanning-probe Raman spectroscopy with single-molecule sensitivity". Phys Rev B 2007; 75:236402.
51. Bailo E, Deckert V. Tip-enhanced Raman spectroscopy of single RNA strands: towards a novel direct-sequencing method. Angew Chem Int Ed Engl 2008; 47:1658-61.
52. Deckert-Gaudig T, Deckert V. Ultraflat transparent gold nanoplates - ideal substrates for tip-enhanced Raman scattering experiments. Small 2009; 5:432-6.
53. Deckert-Gaudig T, Rauls E, Deckert V. Aromatic amino acid monolayers sandwiched between gold and silver: a combined tip-enhanced raman and theoretical approach. J Phys Chem C 2010; 114:7412-20.
54. Shorter J, Lindquist S. Prions as adaptive conduits of memory and inheritance. Nat Rev Genet 2005; 6:435-50.
55. Harris DA, True HL. New insights into prion structure and toxicity. Neuron 2006; 50:353-7.
56. Alberti S, Halfmann R, King O, Kapila A, Lindquist S. A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell 2009; 137:146-58.
57. Tanaka M, Collins SR, Toyama BH, Weissman JS. The physical basis of how prion conformations determine strain phenotypes. Nature 2006; 442:585-9.
58. True HL. The battle of the fold: chaperones take on prions. Trends Genet 2006; 22:110-7.
59. Legname G, Nguyen HO, Baskakov IV, Cohen FE, Dearmond SJ, Prusiner SB. Strain-specified characteristics of mouse synthetic prions. Proc Natl Acad Sci USA 2005; 102:2168-73. (Pubitemid 40262030)
60. Legname G, Nguyen HO, Peretz D, Cohen FE, DeArmond SJ, Prusiner SB. Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc Natl Acad Sci USA 2006; 103:19105-10.
61. Sun Y, Makarava N, Lee CI, Laksanalamai P, Robb FT, Baskakov IV. Conformational stability of PrP amyloid fibrils controls their smallest possible fragment size. J Mol Biol 2008; 376:1155-67.
62. Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF, et al. The most infectious prion protein particles. Nature 2005; 437:257-61.
63. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 1998; 95:6448-53.
64. Conway KA, Lee SJ, Rochet JC, Ding TT, Harper JD, Williamson RE, et al. Accelerated oligomerization by Parkinson's disease linked alpha-synuclein mutants. Ann NY Acad Sci 2000; 920:42-5.
65. Scherzinger E, Lurz R, Turmaine M, Mangiarini L, Hollenbach B, Hasenbank R, et al. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 1997; 90:549-58.
66. Klein WL, Krafft GA, Finch CE. Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci 2001; 24:219-24.
67. Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 2007; 8:101-12.
68. Goldberg MS, Lansbury PT Jr. Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease? Nat Cell Biol 2000; 2:115-9.
69. Orte A, Birkett NR, Clarke RW, Devlin GL, Dobson CM, Klenerman D. Direct characterization of amyloidogenic oligomers by single-molecule fluorescence. P Natl Acad Sci USA 2008; 105:14424-9.
70. Serio TR, Cashikar AG, Kowal AS, Sawicki GJ, Moslehi JJ, Serpell L, et al. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 2000; 289:1317-21.
71. He X, Giurleo JT, Talaga DS. Role of small oligomers on the amyloidogenic aggregation free-energy landscape. J Mol Biol 2009; 395:134-54.
72. Moore RA, Vorberg I, Priola SA. Species barriers in prion diseases - brief review. Arch Virol 2005; 187-202.
73. Vanik DL, Surewicz KA, Surewicz WK. Molecular basis of barriers for interspecies transmissibility of mammalian prions. Mol Cell 2004; 14:139-45.
74. Chiti F, Dobson CM. Protein misfolding, functional amyloid and human disease. Annu Rev Biochem 2006; 75:333-66.
75. Chen B, Bruce KL, Newnam GP, Gyoneva S, Romanyuk AV, Chernoff YO. Genetic and epigenetic control of the efficiency and fidelity of cross-species prion transmission. Mol Microbiol 2010; 76:1483-99.
76. Chen B, Newnam GP, Chernoff YO. Prion species barrier between the closely related yeast proteins is detected despite coaggregation. Proc Natl Acad Sci USA 2007; 104:2791-6.
77. Dobson CM. Principles of protein folding, misfolding and aggregation. Semin Cell Dev Biol 2004; 15:3-16.
78. Dobson CM. Protein misfolding, evolution and disease. Trends Biochem Sci 1999; 24:329-32.
79. Petkova AT, Ishii Y, Balbach JJ, Antzutkin ON, Leapman RD, Delaglio F, et al. A structural model for Alzheimer's beta-amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci USA 2002; 99:16742-7.
80. Perutz MF, Johnson T, Suzuki M, Finch JT. Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc Natl Acad Sci USA 1994; 91:5355-8.
81. Watson D, Castano E, Kokjohn TA, Kuo YM, Lyubchenko Y, Pinsky D, et al. Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease. Neurol Res 2005; 27:869-81.
82. Chen S, Ferrone FA, Wetzel R. Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation. Proc Natl Acad Sci USA 2002; 99:11884-9.
83. Guijarro JI, Sunde M, Jones JA, Campbell ID, Dobson CM. Amyloid fibril formation by an SH3 domain. Proc Natl Acad Sci USA 1998; 95:4224-8.
84. Chiti F, Webster P, Taddei N, Clark A, Stefani M, Ramponi G, et al. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc Natl Acad Sci USA 1999; 96:3590-4.
85. Bader R, Bamford R, Zurdo J, Luisi BF, Dobson CM. Probing the mechanism of amyloidogenesis through a tandem repeat of the PI3-SH3 domain suggests a generic model for protein aggregation and fibril formation. J Mol Biol 2006; 356:189-208. (Pubitemid 43069737)
86. Pellarin R, Caflisch A. Interpreting the aggregation kinetics of amyloid peptides. J Mol Biol 2006; 360:882-92.
87. Knowles TP, Fitzpatrick AW, Meehan S, Mott HR, Vendruscolo M, Dobson CM, et al. Role of intermolecular forces in defining material properties of protein nanofibrils. Science 2007; 318:1900-3.
88. Mukhopadhyay S, Krishnan R, Lemke EA, Lindquist S, Deniz AA. A natively unfolded yeast prion monomer adopts an ensemble of collapsed and rapidly fluctuating structures. Proc Natl Acad Sci USA 2007; 104:2649-54.
89. Kransnoslobodtsev AV, Shlyakhtenko LS, Ukraintsev E, Zaikova TO, Keana JF, Lyubchenko YL. Nanomedicine and protein misfolding diseases. Nanomedicine 2005; 1:300-5.
90. Rubinstein A, Lyubchenko YL, Sherman S. Dynamic properties of pH-dependent structural organization of the amyloidogenic beta-protein (1-40). Prion 2009; 3:31-43.
91. Sorce B, Sabella S, Sandal M, Samori B, Santino A, Cingolani R, et al. Single-molecule mechanical unfolding of amyloidogenic beta(2)-microglobulin: The forcespectroscopy approach. Chemphyschem 2009; 10:1471-7
92. Sandal M, Valle F, Tessari I, Mammi S, Bergantino E, Musiani F, et al. Conformational equilibria in monomeric alpha-synuclein at the single-molecule level. PLoS Biol 2008; 6:6.
93. Brucale M, Sandal M, Di Maio S, Rampioni A, Tessari I, Tosatto L, et al. Pathogenic mutations shift the equilibria of alpha-synuclein single molecules towards structured conformers. Chembiochem 2009; 10:176-83.
94. McAllister C, Karymov MA, Kawano Y, Lushnikov AY, Mikheikin A, Uversky VN, et al. Protein interactions and misfolding analyzed by AFM force spectroscopy. J Mol Biol 2005; 354:1028-42.
95. Lyubchenko YL, Sherman S, Shlyakhtenko LS, Uversky VN. Nanoimaging for protein misfolding and related diseases. J Cell Biochem 2006; 99:53-70.
96. Yu J, Lyubchenko YL. Early stages for Parkinson's development: alpha-synuclein misfolding and aggregation. J Neuroimmune Pharm 2009; 4:10-6.
97. Yu J, Malkova S, Lyubchenko YL. alpha-Synuclein misfolding: single molecule AFM force spectroscopy study. J Mol Biol 2008; 384:992-1001.
98. Perutz MF, Pope BJ, Owen D, Wanker EE, Scherzinger E. Aggregation of proteins with expanded glutamine and alanine repeats of the glutamine-rich and asparagine-rich domains of Sup35 and of the amyloid beta-peptide of amyloid plaques. Proc Natl Acad Sci USA 2002; 99:5596-600.
99. Balbirnie M, Grothe R, Eisenberg DS. An amyloid-forming peptide from the yeast prion Sup35 reveals a dehydrated beta-sheet structure for amyloid. Proc Natl Acad Sci USA 2001; 98:2375-80.
100. Lyubchenko Y, Kim BH, Krasnoslobodtsev A, Yu J. Nanoimaging for protein misfolding diseases. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 2010.
101. Merkel R, Nassoy P, Leung A, Ritchie K, Evans E. Energy landscapes of receptor-ligand bonds explored with dynamic force spectroscopy. Nature 1999; 397:50-3.